Randal J. Kirk, Chief Executive Officer and Chairman of the Board

 

Mr. Kirk founded Third Security, LLC in March 1999 and has served as its Chief Executive Officer since that time. In 1984, Mr. Kirk co-founded General Injectables & Vaccines, Inc. and served as Chairman of the Board prior to the 1998 sale of the company. Mr. Kirk also co-founded King Pharmaceuticals, Inc. in 1993. Additionally, in 1996 Mr. Kirk founded and became Chairman of the Board of New River Pharmaceuticals Inc. (previously traded on NASDAQ prior to its acquisition by Shire plc in 2007) and was President and Chief Executive Officer between October 2001 and April 2007.

Mr. Kirk has served as a member of the Board of Directors of Clinical Data, Inc. since 2002 and as Chairman of the Board since 2004, as a member of the Board of Directors of Halozyme Therapeutics, Inc. (NASDAQ: HALO) since May 2007, as Chairman of the Board of Directors of Intrexon Corporation since February 2008 and as Chairman of the Board of Directors of Cyntellect, Inc. since September 2008. Mr. Kirk served as a member of the Board of Directors of Scios, Inc. (previously traded on NASDAQ prior to its acquisition by Johnson & Johnson) between February 2000 and May 2002.

In 2009, Virginia Governor Timothy M. Kaine appointed Mr. Kirk to serve on the University of Virginia’s Board of Visitors. Prior to that honor, he served as Rector of the Radford University Board of Visitors and also on the University’s Foundation board. In July 2006, Mr. Kirk was chosen by the governor to sit on the Virginia Advisory Council on Revenue Estimates. A year later, he accepted a position on the Board of Directors for the Virginia University Research Partnership.

Mr. Kirk began his professional career in the private practice of law. He holds a B.A. in Business from Radford University and a J.D. from the University of Virginia.